Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Christopher Johns (Sheffield, United Kingdom), Christopher Johns, Dave Capener, Charlotte Hammerton, Kieran Shotton, Charlie Elliot, Robin Condliffe, David Kiely, Jim Wils, Andrew Swift. Cardiopulmonary MR characteristics can estimate mPAP in COPD. Eur Respir J 2016; 48: Suppl. 60, 1884

Member's Comments

No comment yet.

Related content which might interest you: Estimation of mPAP with MRI in pulmonary hypertension subgroups: Comparison with echocardiography Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 NT-proBNP in assessment of pulmonary hypertension in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 Pulmonary hypertension and COPD: Clinical assessment and biomarkers Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Pulmonary hypertension in COPD: results from the ASPIRE registry Source: Eur Respir J 2013; 41: 1292-1301 Year: 2013 Cardiopulmonary exercise test (CPET) may show initial right cardiac dysfunction in patients with moderate-severe chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Best abstracts in physical activity and exercise testing Year: 2014 Usefulness of FVC/DLCO ratio to stratify the risk of mortality in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey Source: International Congress 2014 – Clinical presentations Year: 2014 The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 About cardiac output assessment in pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 CT measured pulmonary artery to aorta ratio as a predictor of pulmonary hypertension in COPD Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Characteristics of pulmonary function of COPD with and without arterial pulmonary hypertension Source: International Congress 2014 – Comorbidities Year: 2014 Role of echocardiography in assessment of pulmonary hypertension secondary to COPD Source: International Congress 2014 – COPD and PAH related imaging Year: 2014 Imaging in assessment of out-of-proportion pulmonary hypertension in patients with COPD Source: Annual Congress 2010 - Parenchmya and bronchial carcinoma Year: 2010 Comparison of CT scan-measured pulmonary artery to aorta ratio of combined pulmonary fibrosis and emphysema (CPFE) and COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Effect of obstructive lung disease on mosaic attenuation patern in CTEPH patient Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Acquisition of echo-Doppler parameters of pulmonary hypertension in COPD Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 Lung perfusion: MRI vs SPECT for screening in suspected chronic thromboembolic pulmonary hypertension Source: International Congress 2016 – Acute pulmonary embolism Year: 2016 Prognostic value of MRI in pulmonary arterial hypertension: Early and late predictors Source: International Congress 2015 – Pulmonary hypertension: new pathophysiological insights Year: 2015